Disagree, Deborah wasn't running a lifestyle company and was actively pursuing shareholder value with BNC210 and other assets. Her biggest mistake was not running the BNC210 trial for PTSD with better controls, but hindsight is 20/20. Before that I can't think of many gripes shareholders and others had on her performance and BNO.
What has EDS done in the last 1.5 years?
BNO Price at posting:
6.1¢ Sentiment: Hold Disclosure: Held
